Literature DB >> 31619808

RNA therapies.

David Payne.   

Abstract

Keywords:  Therapeutics

Mesh：

Substances：

Year:  2019        PMID： 31619808     DOI： 10.1038/d41586-019-03067-5

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

Review 1.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 2.  Lipid-based nanoparticles and RNA as innovative neuro-therapeutics.

Authors:  Maria Tsakiri; Cristina Zivko; Costas Demetzos; Vasiliki Mahairaki
Journal:  Front Pharmacol       Date:  2022-08-09       Impact factor: 5.988

3.  Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).

Authors:  Hanwen Zhang; Shuya Liu; Lian Tang; Jianhua Ge; Xiaobo Lu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.